BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18651348)

  • 1. Aripiprazole reduces serum prolactin in a woman with prolactinoma and acute psychosis.
    Sheldrick AJ; Gründer G
    Pharmacopsychiatry; 2008 Jul; 41(4):160. PubMed ID: 18651348
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of aripiprazole and quinagolide, a dopamine agonist, in a patient with symptomatic pituitary prolactinoma and chronic psychosis.
    Broekhof R; Gosselink MJ; Pijl H; Giltay EJ
    Gen Hosp Psychiatry; 2012; 34(2):209.e1-3. PubMed ID: 21872335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful monotherapy treatment with aripiprazole in a patient with schizophrenia and prolactinoma.
    Freeman B; Levy W; Gorman JM
    J Psychiatr Pract; 2007 Mar; 13(2):120-4. PubMed ID: 17414690
    [No Abstract]   [Full Text] [Related]  

  • 4. Normalization of prolactin with aripiprazole in a patient with psychotic depression and a comorbid pituitary microadenoma.
    Steinhagen CK
    Psychosomatics; 2007; 48(4):350-1. PubMed ID: 17600173
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypogonadism due to hyperprolactinemia and subsequent first episode of psychosis.
    Tsigkaropoulou E; Peppa M; Zompola C; Rizos E; Xelioti I; Chatziioannou S; Filippopoulou A; Lykouras L
    Gend Med; 2012 Feb; 9(1):56-60. PubMed ID: 22333523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin serum concentrations after electroconvulsive therapy in a depressed patient with cabergoline-treated prolactinoma: implications for treatment.
    Feneberg E; Gahr M; Baumgarten E; Connemann B; Merger S; Özpeynirci Y; Schönfeldt-Lecuona C
    J ECT; 2015 Jun; 31(2):e28-9. PubMed ID: 26000778
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of risperidone on prolactinoma growth in a psychotic woman.
    Pal JK; Sarino WA
    Psychosom Med; 2000; 62(5):736-8. PubMed ID: 11020104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyperprolactinemia].
    Müller OA; von Werder K
    Z Arztl Fortbild (Jena); 1991 Feb; 85(3-4):125-30. PubMed ID: 1676201
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolactin, prolactin disorders, and dopamine agonists during pregnancy.
    Levin G; Rottenstreich A
    Hormones (Athens); 2019 Jun; 18(2):137-139. PubMed ID: 30341577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When to discontinue treatment of prolactinoma?
    Wass JA
    Nat Clin Pract Endocrinol Metab; 2006 Jun; 2(6):298-9. PubMed ID: 16932302
    [No Abstract]   [Full Text] [Related]  

  • 11. Major depressive disorder induced by prolactinoma--a case report.
    Liao WT; Bai YM
    Gen Hosp Psychiatry; 2014; 36(1):125.e1-2. PubMed ID: 24182617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recurrence of prolactinoma surveyed. Hormone therapy can safely be withdrawn for a long time in patients with normalized prolactin levels and invisible tumor].
    Werner S
    Lakartidningen; 2004 Oct; 101(41):3162-3. PubMed ID: 15517713
    [No Abstract]   [Full Text] [Related]  

  • 13. [The best approach to treat prolactinoma].
    Zárate A; Saucedo R; Basurto L
    Gac Med Mex; 2004; 140(5):567-9. PubMed ID: 15559242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
    Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A
    Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldosterone response to metoclopramide in patients with prolactinoma: effect of short-term bromocriptine treatment.
    Zacharieva S; Stoeva I; Andreeva M; Kalinov K; Matrozov P; Andonova K
    Methods Find Exp Clin Pharmacol; 1996 Nov; 18(9):593-7. PubMed ID: 9010834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aripiprazole: a new atypical antipsychotic drug].
    Fischer B; Davids E; Gastpar M
    Fortschr Neurol Psychiatr; 2004 Sep; 72(9):497-502. PubMed ID: 15365912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential for long-term remission of microprolactinoma after withdrawal of dopamine-agonist therapy.
    Bronstein MD
    Nat Clin Pract Endocrinol Metab; 2006 Mar; 2(3):130-1. PubMed ID: 16932269
    [No Abstract]   [Full Text] [Related]  

  • 18. [Macroprolactinoma reduction and pregnancy induction with bromocriptine].
    Grimaldo J; López Espinoza E; Villanueva C; Verulo Reyes TB; Ayala AR
    Ginecol Obstet Mex; 1988 Aug; 56():213-7. PubMed ID: 3154241
    [No Abstract]   [Full Text] [Related]  

  • 19. High prolactin level.
    Piketty ML; Nataf F; Dilouya A; Roux FX
    J Neurosurg; 2000 Feb; 92(2):368-9. PubMed ID: 10659034
    [No Abstract]   [Full Text] [Related]  

  • 20. A combined case of macroprolactinoma, growth hormone excess and Graves' disease.
    Hussein Z; Tress B; Colman PG
    Med J Malaysia; 2005 Jun; 60(2):232-6. PubMed ID: 16114168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.